Xwell (XWEL) Cash from Financing Activities (2010 - 2026)
Xwell (XWEL) posted Cash from Financing Activities of $19.2 million for Q1 2026, up 2393.07% sequentially from -$837000.0 in Q4 2025, and up 412.5% YoY from $3.7 million in Q1 2025.
Xwell (XWEL) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Xwell has reported Cash from Financing Activities for 17 years, with the latest figure at $19.2 million in Q1 2026.
- Quarterly Cash from Financing Activities rose 412.5% year-over-year to $19.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.4 million (up 240.98% YoY) and the FY2025 annual result came in at $1.9 million, up 42.9% from the prior year.
- Cash from Financing Activities grew to $19.2 million in Q1 2026 per XWEL's latest filing, from -$837000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $19.2 million in Q1 2026 and troughed at -$13.9 million in Q1 2022.
- A 5-year average of -$375307.7 and a median of -$95000.0 in 2025 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities plunged 1844.36% in 2022, then jumped 803.33% in 2024.
- Over 5 years, Cash from Financing Activities stood at $279000.0 in 2022, then tumbled by 46.24% to $150000.0 in 2023, then surged by 803.33% to $1.4 million in 2024, then plunged by 161.77% to -$837000.0 in 2025, then soared by 2393.07% to $19.2 million in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $19.2 million, -$837000.0, and -$871000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | -1.57 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 7.27 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -325.19 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -144.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -214.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 3.76 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -129.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -317.75 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -229.00 Mn |
| 10 | Xwell | 7.47 Mn | -9.34 Mn | 2.35 Mn | 19.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.19 Mn |
| Mar 31, 2026 | 19.19 Mn |
| Dec 31, 2025 | -837,000.00 |
| Dec 31, 2025 | -837,000.00 |
| Sep 30, 2025 | -871,000.00 |
| Sep 30, 2025 | -871,000.00 |
| Jun 30, 2025 | -95,000.00 |
| Jun 30, 2025 | -95,000.00 |
| Mar 31, 2025 | 3.75 Mn |
| Mar 31, 2025 | 3.75 Mn |
| Sep 30, 2024 | 1.36 Mn |
| Sep 30, 2024 | 1.36 Mn |
| Sep 30, 2023 | 150,000.00 |
| Sep 30, 2023 | 150,000.00 |
| Jun 30, 2023 | -120,000.00 |
| Jun 30, 2023 | -120,000.00 |
| Mar 31, 2023 | -22,000.00 |
| Mar 31, 2023 | -22,000.00 |
| Dec 31, 2022 | 279,000.00 |
| Dec 31, 2022 | 279,000.00 |